Login
Who's Online
We have 135 guests and one member online
Statistics
- Users 5513
- Articles 727
- Articles View Hits 16891425
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- Cell and Gene Therapy CRO Market Expected to Grow at 6.7% CAGR, Reaching $2.43 Billion by 2031 As Revealed ... - WhaTech
Thu, 12 Sep 2024 13:24:2 GMT - A Gene Therapy to Treat the FOXG1 Brain Disorder - The Scientist
Thu, 12 Sep 2024 06:01:3 GMT - Global Cancer Gene Therapy Market Poised for Explosive Growth: Projected CAGR of 10.1% Through 2032 - Future Market Insights
Thu, 12 Sep 2024 06:00:5 GMT - Around the Helix: Cell and Gene Therapy Company Updates – September 11, 2024 - CGTLive™
Thu, 12 Sep 2024 00:41:1 GMT - Cell And Gene Therapy Clinical Trials Market Size to Hit USD 47.40 Bn by 2033 - BioSpace
Wed, 11 Sep 2024 23:44:0 GMT - CPC Launches Aseptic Product for Cell and Gene Therapy Cryopreservation - PR Newswire
Wed, 11 Sep 2024 22:15:0 GMT - Gene Therapy Is Developing Rapidly in the Asia Pacific - Genetic Engineering & Biotechnology News
Wed, 11 Sep 2024 21:14:2 GMT - BridgeBio Pharma Seeks Partner To Develop Gene Therapy For Inherited Condition - Benzinga
Wed, 11 Sep 2024 19:44:1 GMT - New proteolipid vehicles offer advances in gene therapy delivery - Longevity.Technology
Wed, 11 Sep 2024 19:06:5 GMT - BridgeBio trims gene therapy budget after seeing data on adrenal gland medicine - BioPharma Dive
Wed, 11 Sep 2024 17:52:4 GMT - BridgeBio Pharma drops gene therapy program for AAV | Biotechnology | The Pharmaletter - The Pharma Letter
Wed, 11 Sep 2024 17:45:0 GMT - BridgeBio stock slides on discontinuation of CAH gene therapy (NASDAQ:BBIO) - Seeking Alpha
Wed, 11 Sep 2024 17:18:1 GMT - New Jersey college student suffering from sickle cell disease has newfound hope with gene therapy at CHOP - CBS News
Wed, 11 Sep 2024 17:15:4 GMT - BridgeBio to reduce gene therapy budget more than $50M - TipRanks
Wed, 11 Sep 2024 17:02:0 GMT - Cellular Origins & 3P Innovation Partner to Streamline Cell and Gene Therapy Manufacturing - Contract Pharma
Wed, 11 Sep 2024 14:59:0 GMT